Non-clinical development

Anticipate in order to optimize the clinical development of your drug

Provide your project to Forenap at an early stage of development ensures an efficient continuity between the different development stages of your compound.
By managing your non-clinical development, we offer your molecule the best chances of success. The research-based pharmaceutical industry has faced growing challenges in recent years as a result of increased economic and regulatory pressures leading to a need of accelerating drug development processes while respecting quality and regulations requirements.
We combine our expertises in order to optimize the non-clinical/clinical interface: you will have robust studies, compliant with regulations (FDA, EMEA, ICH, GLP), allowing your compound to reach the clinical phase in the best conditions.

Optimize the non-clinical development by a dedicated approach

Your goals are fully respected: our proposal of non-clinical development will be adapted to your objectives. Forenap will also provide you with a strategic approach for your non-clinical development by making proposals designed to anticipate the clinical development of your drug. Our non-clinical development plan will include study designs, schedules and quotations.
The overall vision of your project is essential for the management of all non-clinical studies: we take care of the set-up, the management and the monitoring of these studies. It also allows to anticipate clinical trials submission by an early preparation of required regulatory documents (investigator's brochure, IMPD…).

A la carte services

Proposal of non-clinical development plans with study design, planning and quotation
Study set-up, study management and monitoring
Consulting: review of non-clinical data and scientific advice
Writing and/or review of regulatory documents (IB, IMPD, IND…) for clinical trial submission
Interface with the clinical development department

We rely on a large network of partners with well-identified skills, allowing the whole non-clinical development of your compound. Our good knowledge of this network allows you to get the best of each of these partners.
Active and well-known in the CNS research domain, we have access to a rich and international network of experts in non-clinical and clinical development.

Optimize your drug development by the translational research

Through a network of partners skilled in pharmacology, we can provide you with many animal models to prove efficacy in the targeted therapeutic indications at a very early stage of your drug development. We can also provide you with the same animal models as those proposed in humans by Forenap. This translational research will allow you to chose the appropriate model for a POC (Proof Of Concept) study in humans and make a Go/No-Go decision very early for your drug development.